Filing Details
- Accession Number:
- 0001179110-15-007775
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-14 15:17:57
- Reporting Period:
- 2015-05-12
- Filing Date:
- 2015-05-14
- Accepted Time:
- 2015-05-14 15:17:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219015 | K John Clarke | C/O Cardinal Partners 221 Nassau Street Princeton NJ 08542 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-05-12 | 38,400 | $10.44 | 107,523 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-05-12 | 38,400 | $19.96 | 69,123 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2015-05-12 | 38,400 | $0.00 | 38,400 | $10.44 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-05-26 | 2015-05-26 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $19.88 to $20.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.